Gene therapy company developing treatments for severe and incurable diseases.
Issues related to the reimbursement of gene therapies; issues related to the Patient Affordability and Efficiency Act.
S. 2543, Prescription Drug Pricing Reduction Act; issues related to value-based payment
Issues related to value-based drug pricing and drug pricing in general Provide guidance and strategic counsel with regard to regulations and legislation that could impact the gene therapies, drug pricing, and other issues that impact the industry generally, but bluebird bio specifically
Issues related to gene therapies, drug pricing, and bluebird bio specifically
Issues related to the Patient Affordability and Efficiency Act.
Issues related to H.R. 2296, the METRIC Act.
MMM - Medicare/Medicaid HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
POLSINELLI PC
1401 Eye Street, NW, Suite 800, Washington, DC, 20005, US
ALAN WHEAT (former Member of Congress from Missouri) ALAN WHEAT (former Member of Congress from Missouri)
former Member of Congress from Missouri former Member of Congress from Missouri